Literature DB >> 8256930

Susceptibility of intra-abdominal isolates at operation: a predictor of postoperative infection.

J A Hopkins1, J C Lee, S E Wilson.   

Abstract

Antimicrobial resistance of operative site flora was correlated with postoperative infection in 175 patients undergoing operation for intra-abdominal sepsis: Diagnoses for study patients were acute or gangrenous appendicitis in 48 (27%), complicated appendicitis in 98 (56%), perforated viscus other than appendix in 21 (12%), and eight (5%) had other intra-abdominal infections. One hundred thirty-six (78%) patients were males. The average age was 33 +/- 14 years, average number of hospital days was 11.6 +/- 13.5, and average number of days on antibiotics was 6.9 +/- 2.5. Overall recovery without infection was 75 per cent (131/175). Analysis of susceptibility of 939 intraoperative isolates indicated a significant relationship (P = 0.0002) between resistance to the empiric antimicrobials received and postoperative infection. Of 131 patients with resolution of the intra-abdominal infection, 57 (44%) had resistant isolates while 36 (82%) of 44 patients with postoperative infectious complications had resistant isolates. Streptococcus Group D, Escherichia coli, and Bacteroides fragilis were the most prevalent resistant organisms isolated from both intra- and postoperative cultures. Other variables that were significantly different between those without complications and those who had complications were, respectively: average age 31 versus 38; admission WBC 14.5 versus 16.7; and diagnosis, acute appendicitis 28 per cent versus 2 per cent. A stepwise logistic regression analysis confirmed the predictive value of intraoperative isolate resistance, age, and admission WBC, in that order, on outcome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8256930

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  7 in total

1.  Microdialysis study of imipenem distribution in the intraperitoneal fluid of rats with or without experimental peritonitis.

Authors:  Sandrine Lefeuvre; Sandrine Marchand; Isabelle Lamarche; Olivier Mimoz; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Canadian practice guidelines for surgical intra-abdominal infections.

Authors:  Anthony W Chow; Gerald A Evans; Avery B Nathens; Chad G Ball; Glen Hansen; Godfrey Km Harding; Andrew W Kirkpatrick; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

3.  Effect of inappropriate initial empiric antibiotic therapy on outcome of patients with community-acquired intra-abdominal infections requiring surgery.

Authors:  K Krobot; D Yin; Q Zhang; S Sen; A Altendorf-Hofmann; J Scheele; W Sendt
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-21       Impact factor: 3.267

4.  Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections.

Authors:  Philippe Montravers; Annie Chalfine; Remy Gauzit; Alain Lepape; Jean Pierre Marmuse; Corinne Vouillot; Claude Martin
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

Review 5.  Model systems for the study of Enterococcal colonization and infection.

Authors:  H M Sharon Goh; M H Adeline Yong; Kelvin Kian Long Chong; Kimberly A Kline
Journal:  Virulence       Date:  2017-05-04       Impact factor: 5.882

6.  Optimal First-Line Antibiotic Treatment for Pediatric Complicated Appendicitis Based on Peritoneal Fluid Culture.

Authors:  Tsubasa Aiyoshi; Kouji Masumoto; Nao Tanaka; Takato Sasaki; Fumiko Chiba; Kentaro Ono; Takahiro Jimbo; Yasuhisa Urita; Toko Shinkai; Hajime Takayasu; Shigemi Hitomi
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2021-11-05

7.  [Study of early relaparotomies at the University Hospitals of Lubumbashi: epidemiological clinical and therapeutic features].

Authors:  Catherine Saleh Ugumba; Marc Kashal Kasong; Cedrick Sangwa Milindi; Gabriel Wakunga Warach; François Tshilombo Katombe; Etienne Odimba Bfkoshe
Journal:  Pan Afr Med J       Date:  2018-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.